What is the current status of HR 6867?

HR 6867 is currently: Introduced.

Who sponsored HR 6867?

HR 6867 was sponsored by Robin Kelly (D), Rep.

Diversity in Clinical Trials Bill

IntroducedDecember 18, 2025

Introduced10 months ago

Intro

House

Senate

Pres

Introduced in House

Why This Matters

The NIH Clinical Trial Integrity Act aims to ensure that clinical trials include a diverse range of participants, making research results more applicable to the general population. This is important for improving health outcomes for everyone.

If you participate in clinical trials, your experience may become easier and more inclusive of different backgrounds.

Who this affects

Patients with health conditions · Underrepresented racial groups · Underrepresented ethnic groups

What changes is this bill making?

1This bill requires clinical trials to include diverse participants based on race, ethnicity, age, and sex.
2Sponsors must set clear goals for recruiting and keeping participants from different backgrounds.
3The bill mandates a detailed plan for how trials will meet these diversity goals.
4It encourages less burdensome follow-up options for trial participants, like virtual visits.
5Researchers must receive training on how to include diverse groups in their studies.

Last changed 5 months ago · checked hourly

Diversity in Clinical Trials Bill

IntroducedDecember 18, 2025

Introduced10 months ago

Intro

House

Senate

Pres

Introduced in House

Why This Matters

If you participate in clinical trials, your experience may become easier and more inclusive of different backgrounds.

Who this affects

Patients with health conditions · Underrepresented racial groups · Underrepresented ethnic groups

What changes is this bill making?

1This bill requires clinical trials to include diverse participants based on race, ethnicity, age, and sex.
2Sponsors must set clear goals for recruiting and keeping participants from different backgrounds.
3The bill mandates a detailed plan for how trials will meet these diversity goals.
4It encourages less burdensome follow-up options for trial participants, like virtual visits.
5Researchers must receive training on how to include diverse groups in their studies.

Last changed 5 months ago · checked hourly